Nippon India Pharma Fund
AstraZeneca Pharma India Limited · NSE
62,568 sh · ₹50.68 Cr
Nippon India Small Cap Fund
0.7% of their portfolio
₹536.12 Cr
6,61,875 sh
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
1.9% of their portfolio
₹126.21 Cr
1,55,814 sh
ICICI Prudential Quality Fund
3.0% of their portfolio
₹65.61 Cr
81,005 sh
ICICI Prudential Multicap Fund
0.3% of their portfolio
₹63.40 Cr
78,271 sh
Nippon India Pharma Fund
0.6% of their portfolio
₹50.68 Cr
62,568 sh
ICICI Prudential Innovation Fund
0.5% of their portfolio
₹37.87 Cr
46,755 sh
ICICI Prudential Smallcap Fund
0.3% of their portfolio
₹27.52 Cr
33,970 sh
ICICI Prudential Active Momentum Fund
0.9% of their portfolio
₹18.08 Cr
22,319 sh
ICICI Prudential Retirement Fund - Hybrid Aggressive Plan
1.2% of their portfolio
₹14.95 Cr
18,451 sh
ICICI Prudential Manufacturing Fund
0.1% of their portfolio
₹10.71 Cr
13,226 sh
ICICI Prudential MNC Fund
0.5% of their portfolio
₹9.26 Cr
11,437 sh
ICICI Prudential ESG Exclusionary Strategy Fund
0.6% of their portfolio
₹7.56 Cr
9,332 sh
FII holding ~flat QoQ
Jun 2026 quarter
Ownership by quarter
Promoter
— 0.0pp
Nippon India Pharma Fund
AstraZeneca Pharma India Limited · NSE
62,568 sh · ₹50.68 Cr
ICICI Prudential Retirement Fund - Pure Equity Plan
AstraZeneca Pharma India Limited · NSE
8,122 sh · ₹6.58 Cr
ICICI Prudential Retirement Fund - Hybrid Aggressive Plan
AstraZeneca Pharma India Limited · NSE
18,451 sh · ₹14.95 Cr
ICICI Prudential Active Momentum Fund
AstraZeneca Pharma India Limited · NSE
22,319 sh · ₹18.08 Cr
ICICI Prudential Smallcap Fund
AstraZeneca Pharma India Limited · NSE
33,970 sh · ₹27.52 Cr
ICICI Prudential Innovation Fund
AstraZeneca Pharma India Limited · NSE
46,755 sh · ₹37.87 Cr
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
AstraZeneca Pharma India Limited · NSE
1,55,814 sh · ₹126.21 Cr
ICICI Prudential Quality Fund
AstraZeneca Pharma India Limited · NSE
81,005 sh · ₹65.61 Cr
The announcements library is part of Pro.
Every exchange filing this company makes — results, board meetings, dividends, analyst meets, investor presentations — as filed with NSE / BSE, the day it lands.
23 announcements on record for this company.
Promoter holding by quarter: Jun 2025 75.0%, Sep 2025 75.0%, Dec 2025 75.0%, Mar 2026 75.0%. Sep 2024, Dec 2024, Mar 2025: no filing.
FII
— +0.1pp
FII holding by quarter: Jun 2025 3.0%, Sep 2025 2.7%, Dec 2025 2.7%, Mar 2026 2.8%. Sep 2024, Dec 2024, Mar 2025: no filing.
DII
— +0.2pp
DII holding by quarter: Jun 2025 4.5%, Sep 2025 5.3%, Dec 2025 5.5%, Mar 2026 5.8%. Sep 2024, Dec 2024, Mar 2025: no filing.
MF
— +0.2pp
MF holding by quarter: Jun 2025 4.3%, Sep 2025 5.0%, Dec 2025 5.4%, Mar 2026 5.7%. Sep 2024, Dec 2024, Mar 2025: no filing.
Per-series scale, bounds labeled. Gaps mark quarters without a filing.
ICICI Prudential ESG Exclusionary Strategy Fund
AstraZeneca Pharma India Limited · NSE
9,332 sh · ₹7.56 Cr
Nippon India Small Cap Fund
AstraZeneca Pharma India Limited · NSE
6,61,875 sh · ₹536.12 Cr
Ownership by quarter
Promoter
— 0.0pp
Promoter holding by quarter: Jun 2025 75.0%, Sep 2025 75.0%, Dec 2025 75.0%, Mar 2026 75.0%. Sep 2024, Dec 2024, Mar 2025: no filing.
FII
— +0.1pp
FII holding by quarter: Jun 2025 3.0%, Sep 2025 2.7%, Dec 2025 2.7%, Mar 2026 2.8%. Sep 2024, Dec 2024, Mar 2025: no filing.
DII
— +0.2pp
DII holding by quarter: Jun 2025 4.5%, Sep 2025 5.3%, Dec 2025 5.5%, Mar 2026 5.8%. Sep 2024, Dec 2024, Mar 2025: no filing.
MF
— +0.2pp
MF holding by quarter: Jun 2025 4.3%, Sep 2025 5.0%, Dec 2025 5.4%, Mar 2026 5.7%. Sep 2024, Dec 2024, Mar 2025: no filing.
Per-series scale, bounds labeled. Gaps mark quarters without a filing.
The announcements library is part of Pro.
Every exchange filing this company makes — results, board meetings, dividends, analyst meets, investor presentations — as filed with NSE / BSE, the day it lands.
23 announcements on record for this company.